Taspoglutide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTaspoglutide
Drug Alias Name他泊鲁肽BIM-51077BN-51077RO-5073031BM-51077 +[8] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[49] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesIpsen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Diagnostics GmbhF. Hoffmann-La Roche LtdCatalent Germany Schorndorf Gmbh +[4] 
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG